Balanced news tone
News Sentiment
SERA sentiment intelligence
Sera Prognostics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
84/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, +5.3% over four weeks, trend inactive, and below fair value.
abrdn Group holds 7.21% of Sera Prognostics (SERA) stock
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Sera Prognostics CEO Lindgardt sells $43,170 in company stock
Zhenya Lindgardt, CEO of Sera Prognostics (NASDAQ:SERA), sold 20,755 shares for $43,170 to cover tax obligations related to restricted stock units. This sale, at a weighted average price of $2.08 per share, was non-discretionary and followed company policy. The company recently r
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 10 Jun 2026 22:09
- Source
- Investing.com
[144] SERA PROGNOSTICS, INC. SEC Filing
This SEC filing (Form 144) for Sera Prognostics, Inc. details the proposed sale of 5,440 Class A Common shares by an individual named Austin Aerts, acquired through Restricted Stock Unit Vesting on June 9, 2026. The shares, valued at $11,324, are to be sold through Morgan Stanley
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:24
- Source
- Stock Titan
[Form 4] SERA PROGNOSTICS, INC. Insider Trading Activity
SERA PROGNOSTICS, INC.'s CEO, Zhenya Lindgardt, sold 20,755 shares of Class A common stock at a weighted average price of $2.08 per share. This transaction was a "sell to cover" to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs), not a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 20:09
- Source
- Stock Titan
Sera Prognostics (SERA) CFO sells shares to cover RSU tax obligations
Sera Prognostics CFO Austin Aerts sold 5,440 shares of Class A common stock at a weighted average price of $2.08 per share. This sale was explicitly non-discretionary, mandated by a "sell to cover" election to satisfy tax withholding obligations from the vesting of restricted sto
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jun 2026 14:39
- Source
- Stock Titan
Director at Sera Prognostics (SERA) sells 1,560 planned shares
Sera Prognostics director Sandra AJ Lawrence sold 1,560 shares of Class A common stock on June 8, 2026, at a weighted average price of $2.15 per share. The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 10, 2025, indicating it was a routin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jun 2026 20:39
- Source
- Stock Titan
Sera Prognostics, Inc. 8-K SEC Filing June 2026 – Submission of Matters to a Vote of Security Holders
Sera Prognostics, Inc. announced the results of its 2026 Annual Meeting of Stockholders, held on June 4, 2026. Shareholders re-elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence to the Board of Directors and ratified the appointment of Ernst & Young LLP as the company's independ
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 Jun 2026 02:39
- Source
- Minichart
Sera Prognostics (NASDAQ: SERA) 2026 meeting backs board and Ernst & Young
Sera Prognostics, Inc. held its 2026 annual stockholders meeting, with 67.5% of eligible shares represented. Stockholders elected Kim Kamdar, Ph.D. and Sandra A. J. Lawrence as Class II directors, and ratified Ernst & Young LLP as the independent registered public accounting firm
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 21:39
- Source
- Stock Titan
Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Jackson Benjamin
This document is a Statement of changes in beneficial ownership of securities for Sera Prognostics. The filing indicates that Officer Jackson Benjamin has experienced changes in their beneficial ownership. This type of filing is typically made by company insiders to report transa
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jun 2026 08:10
- Source
- Moomoo
SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 20:05
- Source
- PR Newswire
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- Market source
Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Market source
Will Sera Prognostics (NASDAQ:SERA) Spend Its Cash Wisely?
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 08 May 2026 07:00
- Source
- Market source
Sera Prognostics, Inc. Q1 2026 Earnings Call Summary
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 May 2026 12:30
- Source
- Moby
Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 05 May 2026 07:00
- Source
- StockStory
Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 27 Apr 2026 07:00
- Source
- Market source
A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks’ Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 02 Apr 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Mar 2026 07:00
- Source
- Market source
SERA PROGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Mar 2026 07:00
- Source
- PR Newswire
Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Mar 2026 07:00
- Source
- StockStory
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 Mar 2026 07:00
- Source
- Market source
SERA PROGNOSTICS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 Nov 2025 08:00
- Source
- PR Newswire